Empro Group Inc. Ordinary shares
EMPG · Price history
Company & revenue
About Empro Group Inc. Ordinary shares
Primary reporting period: 2024-12-31 · Research updated Oct 12, 2026. A research update is not a new financial filing.
Who they are
EMPG is a Malaysian-based beauty and personal care brand that has broadened its scope significantly. Initially specializing in eyebrow embroidery, the company has since expanded its product lines to encompass cosmetics, skincare, and healthcare items. Its distribution network now reaches customers throughout Southeast Asia and Europe.
How they make money
Empro Group Inc. operates as a distributor of healthcare and beauty products. The company generates revenue primarily through the sale of these consumer-facing goods to customers in Malaysia and international markets, managing supply chain and distribution logistics to fulfill orders.
Products & services
Healthcare and beauty products.
Brands & revenue mix
No separate brand or brand-level revenue disclosure was confirmed in the reviewed sources. This does not mean the company has no brands.
Product / operating segments
No reconciled product or operating-segment revenue breakdown is available for the current research period. Company-wide revenue remains separate from segment disclosure.
Geographic revenue
No reconciled geographic revenue breakdown was confirmed for the current research period.
Customer concentration
No quantified customer-concentration disclosure is available in the current saved research.
Suppliers, materials & equipment
No supplier relationships were confirmed in the sources reviewed. This does not mean the company has no suppliers.
Sources
Wall Street Score
Overall investment score · Quality, value, risk and opportunity
35
Poor
View category scores →
Company Quality
How good is the actual business—regardless of today’s stock price?
69
Fair
Financial Strength
63
Business Quality / Moat
38
Management
100
Growth Quality
97
Risk / Durability
60
Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.
Opportunity
Opportunity Score · How does the current price compare with estimated value?
18
Avoid
Based on current valuation, company quality, recent trends, and available market signals.
View score details →
Model Outlook
12-month model · What does the model think happens next?
25/100
Building Historical Record
Model Score 25/100 — estimates relative performance potential, distinct from the overall Wall Street Score and the separate Company Quality score.
Probability unavailable — the model has not produced a calibrated probability yet.
Click for full breakdown →
WSS View
The quick read
The overall Wall Street Score is low across its combined quality, valuation and risk inputs. This can reflect an expensive share price, business weaknesses, or both; check Company Quality and the category breakdown before drawing a conclusion.
At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.
The model outlook is currently cautious.
No strong positive signal is being highlighted from the currently available summary data.
- •Valuation is a weaker part of the current profile
- •Revenue fundamentals are weak
- •Asset quality is a weaker factor
Company-specific research
Questions worth answering for EMPG
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
- •Can EMPG maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
- •How long can EMPG fund negative free cash flow using its current cash position before it may need more debt or new shares?
- •Is EMPG's debt load manageable relative to cash generation, interest costs and upcoming maturities?
- •What future growth or profitability would be needed to justify EMPG's current valuation?
Essential Investment Snapshot
Wall Street Score
35
Opportunity Score
18
Market Cap
$143.0M
P/E Ratio
184.9
EPS
$0.09
52-Week High
$18.14
52-Week Low
$2.55
Beta
-3.91
Intrinsic Value
$0.80
Shares Outstanding
8.0M
Total Revenue
$5.5M
Total Debt
$1.5M
Dividend
No current dividend
Liquidation Value / Share
$0.19
Momentum & Volatility Signals
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
Community Sentiment
0 active · 0 total callsNo personal call yet on EMPG.
Potential upside factors
- +Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
Potential downside factors
- −Key risks may include competition, margin pressure, debt levels, valuation risk, and changes in demand within the Medical - Distribution industry.
- −Negative free cash flow may increase the need for outside financing and dilution.
These research factors come from saved company research and financial data, not community votes. They are starting points to verify against filings, not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdownWas this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
Score Changes
7 historical score records availablePrevious Score
35
Sep 21, 2026
Change
Unchanged
Current Score
35
Oct 1, 2026
Category Changes
EMPG score was unchanged.
Projected Score
Projected Score
33
Projected Change
-2.2 points
Preliminary comparable-period financial changes suggest decline of approximately 2.2 points. This is a projected estimate, not the official WallStreetScore.
Price vs. Value
OvervaluedCurrent Price
$17.36
Model Intrinsic Value
$0.80
Difference
+$16.56
+2075.0% vs IV
Margin of Safety
-2075.0%
Financial Charts
Revenue
Additional Metrics
Operating Cash Flow
Total Debt
Total Assets
Net Margin %
Free includes 3 annual periods plus available TTM; Premium includes up to 10 annual periods. History depends on available company filings. Swipe the table horizontally to see older periods. A dash means unavailable, not zero.
| Line Item | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | $5.5M | $3.7M | $10.8M | ···· |
| Cost of Revenue | $2.1M | $2.2M | $7.8M | ···· |
| Gross Profit | $3.4M | $1.5M | $3.0M | ···· |
| Research & Development | $0.00 | $0.00 | $0.00 | ···· |
| SG&A Expenses | $2.3M | $1.7M | $1.3M | ···· |
| Operating Expenses | $2.3M | $1.7M | $1.3M | ···· |
| EBITDA | $1.5M | $35K | $1.8M | ···· |
| Operating Income | $1.1M | -$234K | $1.6M | ···· |
| Interest Expense | $112K | $67K | $29K | ···· |
| Income Before Tax | $991K | -$291K | $1.6M | ···· |
| Income Tax Expense | $239K | $27K | $451K | ···· |
| Net Income | $751K | -$318K | $1.2M | ···· |
| Basic EPS | $0.09 | $-0.04 | $0.15 | ···· |
| Basic Shares | 8.00M | 8.00M | 8.00M | ···· |
| Diluted Shares | 8.00M | 8.00M | 8.00M | ···· |
Earnings Summary
Revenue
$5.5M
Estimate unavailable.
Revenue Beat/Miss
Not available (no estimate stored)
EPS
$0.09
Estimate unavailable.
EPS Beat/Miss
Not available (no estimate stored)
Debt Change
-0.8%
Cash Change
-61.7%
Margin Change
+22.3 pp
Debt and cash show percentage changes versus the comparison period; margin shows the change in percentage points (pp). These are company-wide changes, not per-share amounts.
Financial Changes Since Prior Period
What Improved
- Margins expanded
- Debt reduced
What Weakened
- Cash position declined
Potential Score Impact
Positive indicators included revenue growth, debt levels, net income margin. Pressure indicators included EPS growth, cash levels. These factors may support or pressure the Revenue, Management, Financial, and Debt categories; this summary does not claim that the stored scores changed.
Stored Earnings Analysis
Revenue increased 48.4%. EPS declined 336.5%. Cash declined 61.7%. Total debt declined 0.8%. Net income margin improved by 22.3 percentage points.
Earnings-Call Transcript
Earnings-call transcript analysis is not currently available.
These results may influence future scores when the next evaluation is completed.
Insider Activity
Guru / Smart Money
Guru Score
Smart Money
Number of Gurus
Total Guru Value
Avg Portfolio Weight
Largest Holder
Largest Holder %
New Positions
Increased Positions
Reduced Positions
Exited Positions
Net Guru Sentiment
Short Interest
Dividend History
Dividend data is not available yet. Missing data does not mean this company pays no dividend.
Conservative Projected Values
3 Years
$———.——
5 Years
$———.——
10 Years
$———.——
Conservative Projection Rate
——%
Conservative Projected Values — price projections derived from actual 10-year adjusted historical returns, conservatively adjusted and capped at 8% annually. These are distinct from the Outperformance Model Score and WallStreetScore.
Conservative Projected Values
Premium unlocks the 3-year, 5-year, and 10-year conservative projected values with full calculation breakdowns based on actual historical returns.
Start 7-Day Free TrialHistorical Outperformance Record
Premium includes stored forecasts and any available evaluated results. Completed results, win rates and calibrated probabilities are shown only when supported records exist; access does not create historical outcomes.
Start 7-Day Free TrialHistorical Trends
7 historical recordsHistorical Score Chart
3 of 7 records shownWall Street Score
Debt Score
Revenue Score
Asset Score
Capital Score
Management Score
Moat Score
Valuation Score
Buffett Score
Intrinsic Value
Value Reference
Margin of Safety %
Related Companies
Medical - DistributionNews
No news available for EMPG.
Rumor Mill · EMPG
Corporate developments & opportunities
No reviewed developments match this filter.
Evidence credibility is not a forecast of stock performance. Rumor Mill is separate from the WSS score.
Related Stock Research
Continue researching this company with related Wall Street Score rankings and investing guides.
Score Alerts
Premium unlocks alerts when a score rises, falls, or reaches your target price.
Start 7-Day Free TrialPortfolio Score
Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.
Start 7-Day Free Trial